tiprankstipranks
Trending News
More News >
Regenicin Inc (RGIN)
OTHER OTC:RGIN
US Market
Advertisement

Regenicin (RGIN) Income Statement

Compare
4 Followers

Regenicin Income Statement

Last quarter (Q1 2023), Regenicin's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Regenicin's net income was $-336.44K. See Regenicin’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -601.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 601.18K$ 635.86K$ 510.82K$ 736.55K$ 789.11K
Depreciation and Amortization
$ 1.82K$ 0.00$ 206.30K$ 171.86K$ 161.14K
EBITDA
$ -601.00K$ -636.00K$ -511.00K$ -737.00K$ -789.10K
Operating Income
$ -601.00K$ -635.86K$ -511.00K$ -737.00K$ -789.10K
Other Income/Expenses
$ -38.08K$ -34.74K$ -48.77K$ -21.90K$ -18.78K
Pretax Income
$ -639.00K$ -671.00K$ -560.00K$ -758.00K$ -559.06K
Net Income
$ -639.00K$ -670.60K$ -560.00K$ -758.00K$ -559.06K
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ -0.01$ 0.00
Diluted EPS
$ 0.00$ 0.00$ 0.00$ -0.01$ 0.00
Weighted Average Shares Outstanding
153.48M 153.48M 153.48M 153.48M 153.48M
Weighted Average Shares Outstanding (Diluted)
153.48M 153.48M 153.48M 153.48M 153.48M
Currency in USD

Regenicin Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis